Clinical Trials for Opus Genetics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Opus Genetics

Clinical Trials (2)

NCT07185256
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
PHASE1/PHASE2Recruiting
10 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2030
4 conditions1 sponsor1 location
NCT05616793
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
PHASE1/PHASE2Recruiting
15 participants
Started: Jun 15, 2023 · Completed: Jun 15, 2028
1 condition2 sponsors1 location